Advertisement
  • Forward Look

    Immunotherapy in Advanced Hodgkin Lymphoma

    Patients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.

    by Susan Kreimer

  • Forward Look

    Rinse and Recurrence

    Saliva test can help identify people who are at high risk of recurrence after mouth or throat cancer treatment.

    by Eric Fitzsimmons

  • Forward Look

    Upfront Immunotherapy in Early-stage Liver Cancer

    Researchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.

    by Christina Szalinski

  • Forward Look

    The Overlooked Issue of Hearing Loss

    Study underscores importance of regular hearing tests for those who receive cisplatin chemotherapy.

    by Risa Kerslake

  • Overcoming Resistance

    People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.

    by Kendall K. Morgan

  • Survivor Profile

    A Pediatric Cancer Survivor Helps Kids Cope

    Ethan Schilling was treated for a brain tumor at age 12. Now a psychologist, he helps children find the tools to adjust to a new reality after cancer.

    by Sharon Tregaskis

  • Q&A

    A Journey of Self-discovery

    Kailee McGee’s short film explores how a breast cancer diagnosis reshaped how she sees herself.

    by Tyler Santora

  • Get Involved

    Stitching Support

    Fourteen-year-old Giuliana Demma sews colorful hospital gowns for children receiving cancer treatment.

    by Thomas Celona

  • Treating HER2-ultralow Breast Cancer

    FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.

    by Sandra Gordon

  • Screening Options for People With Dense Breasts

    Reports on breast density inform women of their status but raise questions about what to do next.

    by Robin Roenker